Viridian Therapeutics (VRDN) Q2 2025 Earnings

May 6Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.15
-1.04
-0.92
-0.81

Details

Expected EPS
-0.966807
Actual EPS
-0.87
Surprise EPS
0.1
Surprise Percent
+10.01%

Description

⁨Viridian Therapeutics⁩ (⁦VRDN⁩) has reported earnings of ⁦-0.87⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts